Standard Biotools Income Statement (2010-2026) | LAB

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	31.02M	28.50M		26.50M	18.78M	25.65M	27.02M	25.12M	27.67M	25.37M	28.19M	45.54M	22.49M	22.09M	24.78M	40.80M	21.76M	19.55M	23.80M	21.15M
Cost of Revenue (Quarter)	1.87M	1.51M		1.93M	14.35M	16.43M	15.85M	12.84M	14.06M	14.21M	14.83M	21.35M	12.12M	9.96M	13.42M	21.05M	11.13M	10.07M	12.41M	9.84M
Gross Profit (Quarter)	29.15M	27.00M		24.58M	4.43M	9.22M	11.17M	12.28M	13.60M	11.15M	13.36M	24.19M	10.37M	12.13M	11.36M	19.74M	10.63M	9.48M	11.38M	11.31M
Operating items
Research & Development (Quarter)	9.44M	9.21M		8.87M	12.61M	8.49M	7.42M	6.43M	6.18M	6.37M	6.91M	15.98M	7.24M	6.94M	7.04M	11.33M	6.22M	6.36M	7.97M	2.12M
Selling, General & Administrative (Quarter)	24.25M	24.07M		30.88M	30.08M	26.34M	20.22M	21.30M	22.60M	22.29M	21.35M	46.94M	24.86M	24.47M	27.32M	38.71M	28.11M	26.59M	25.34M	18.61M
Restructuring Costs (Quarter)					0.30M	3.40M	-1.25M	1.20M	2.27M	1.67M	1.08M	17.16M	2.78M	5.08M	2.96M	1.55M	1.73M	9.43M	-10.54M
Other Operating Expenses (Quarter)	14.60M	14.84M		14.27M		0.02M	5.88M	-45.05M	-39.56M	-41.20M	-55.28M	-50.02M	-57.67M	-26.94M	-34.05M	1.12M	0.27M	0.04M	13.27M	3.08M
Operating Expenses (Quarter)	48.29M	48.12M		54.01M	42.99M	38.25M	32.28M	28.87M	31.05M	32.33M	34.74M	84.37M	40.63M	38.83M	37.44M	52.71M	36.33M	42.42M	36.03M	23.80M
Operating Income (Quarter)	-17.27M	-19.61M		-27.50M	-38.56M	-29.03M	-21.11M	-16.59M	-17.45M	-21.17M	-21.39M	-60.18M	-30.26M	-26.70M	82.42M	-32.97M	-25.70M	-32.94M	-24.64M	-12.50M
EBIT (Quarter)	-17.27M	-19.61M		-27.50M	-38.56M	-29.03M	-21.11M	-16.59M	-17.45M	-21.17M	-21.39M	-60.18M	-30.26M	-26.70M	82.42M	-32.97M	-25.70M	-32.94M	-24.64M	-12.50M
Non-operating items
Non Operating Investment Income (Quarter)
Other Non Operating Income (Quarter)	0.50M	0.32M		0.12M	-0.17M	-0.06M	0.12M	1.13M			1.10M	-2.23M	0.41M			3.87M	4.96M		0.96M	-5.63M
Non Operating Income (Quarter)	0.50M	0.32M		0.12M	-0.17M	-0.06M	-0.70M	1.13M	0.47M	-0.12M	1.10M	-2.23M	0.41M	0.96M	-4.14M	3.87M	4.96M	-2.09M	0.96M	-5.63M
Net income details
EBT (Quarter)	-17.66M	-15.27M		-76.86M	-65.15M	-30.14M	-20.77M	-16.58M	-16.74M	-20.95M	20.65M	-32.03M	-25.41M	-21.80M	39.25M	-26.18M	-18.28M	-32.90M	6.14M	-14.62M
Tax Provisions (Quarter)	-0.52M	-1.40M		-0.57M	-1.60M	-0.71M	3.39M	0.30M	0.30M	0.10M	-0.03M	0.13M	0.04M	0.10M	0.27M	-0.15M	-0.61M	-1.22M	2.79M	0.01M
Profit After Tax (Quarter)	-17.14M	-13.84M		-76.29M	-63.54M	-29.43M	-20.84M	-16.84M	-17.04M	-21.00M	-19.78M	-32.16M	-45.72M	-21.92M	-27.17M	-26.03M	-33.46M	-31.68M	19.28M	-14.63M
Income from Continuing Operations (Quarter)	-17.14M	-13.87M		-76.29M	-63.55M	-29.43M	-24.17M	-16.88M	-17.04M	-21.05M	20.68M	-32.16M	-25.44M	-21.90M	38.97M	-26.03M	-17.67M	-31.68M	3.35M	-14.63M
Consolidated Net Income (Quarter)	-17.14M	-13.87M		-76.29M	-63.55M	-29.43M	-24.17M	-16.88M	-17.04M	-21.05M	20.68M	-32.16M	-20.27M	-5.02M	-6.90M	-26.03M	-15.79M	-3.00M	5.38M	141.69M
Income towards Parent Company (Quarter)	-17.14M	-13.87M		-76.29M	-63.55M	-29.43M	-24.17M	-16.88M	-17.04M	-21.05M	20.68M	-32.16M	-20.27M	-5.02M	-6.90M	-26.03M	-15.79M	-3.00M	5.38M	141.69M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-17.14M	-13.87M		-76.29M	-63.55M	-29.43M	-24.17M	-16.88M	-17.04M	-21.05M	20.68M	-32.16M	-25.44M	-26.94M	13.87M	-26.03M	-17.67M	-34.69M	-2.17M	141.69M
Additional items
EPS (Basic) (Quarter)	-0.23	-0.18		-0.99	-0.82	-0.37	-0.26	-0.21	-0.22	-0.27	-0.25	-0.27	-0.07	-0.07	0.05	-0.07	-0.05	-0.09	0.05	0.33
EPS (Weighted Average and Diluted) (Quarter)	-0.23	-0.18		-0.99	-0.82	-0.37	-0.26	-0.21	-0.22	-0.27	-0.25	-0.27	-0.07	-0.07	0.05	-0.07	-0.09	-0.09	0.05	0.33
Shares Outstanding (Weighted Average) (Quarter)	75.08M	76.30M	75.79M	77.03M	77.43M	77.92M	78.31M	79.08M	78.87M	78.97M	79.16M	294.12M	372.33M	346.09M	353.25M	378.23M	380.50M	382.63M	381.62M	388.20M
Shares Outstanding (Diluted Average) (Quarter)	75.45M	76.30M	75.79M	77.03M	77.43M	78.90M	78.31M	79.08M	78.67M	79.15M	79.16M	294.12M	372.33M	346.09M	353.25M	378.23M	379.37M	380.47M	381.62M	388.20M
EBITDA (Quarter)	-17.27M	-19.61M		-27.50M	-38.56M	-29.03M	-21.11M	-16.59M	-17.45M	-21.17M	-21.39M	-60.18M	-30.26M	-26.70M	82.42M	-32.97M	-25.70M	-32.94M	-24.64M	-12.50M
Interest Expenses (Quarter)	0.90M	0.97M		1.03M	1.06M	1.05M	1.19M	0.06M	1.13M	1.22M	1.10M	1.03M	0.86M	0.85M	0.57M	0.00M	0.01M	0.01M	0.01M
Tax Rate (Quarter)	2.93%	9.17%		0.75%	2.46%	2.37%	-16.33%	-1.81%	-1.79%	-0.48%	-0.15%	-0.40%	-0.15%	-0.46%	0.69%	0.58%	3.33%	3.70%	45.48%	-0.08%

Research Tools

Standard Biotools Income Statement (2010-2026) | LAB

Create an account

Sign In

Reset Password